Sana Biotechnology sells 21,607,878 shares via ATM for net proceeds of $69 million
PUBT · 05/15 13:02
Share
Listen to the news
- Sana Biotechnology sold 21,607,878 common shares through its at-the-market facility for net proceeds of about $69 million.
- Total capital raised since end of Q1 2026 reached about $94 million, including a previously announced $25 million investment from Mayo Clinic.
- Cash runway now expected to extend to mid-2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sana Biotechnology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605150900PRIMZONEFULLFEED9721066) on May 15, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending